<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02814578</url>
  </required_header>
  <id_info>
    <org_study_id>AMCCV2016-02</org_study_id>
    <nct_id>NCT02814578</nct_id>
  </id_info>
  <brief_title>Assessment of Coronary Artery Lesion Using Optical Coherence Tomography Versus IntraVascular Ultrasound for BiorEsorbable Vascular Scaffold Implantation</brief_title>
  <acronym>ACTIV-BVS</acronym>
  <official_title>Assessment of Coronary Artery Lesion Using Optical Coherence Tomography Versus IntraVascular Ultrasound for BiorEsorbable Vascular Scaffold Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Young-Hak Kim, MD, PhD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Abbott Medical Devices</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Asan Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective is to determine whether IVUS- (vs. OCT-) guided BVS implantation is
      non-inferior to achieve a large in-scaffold minimal lumen area (primary endpoint) measured by
      OCT at 1-year follow-up.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    OCT cost is high
  </why_stopped>
  <start_date type="Actual">July 31, 2017</start_date>
  <completion_date type="Actual">July 31, 2017</completion_date>
  <primary_completion_date type="Actual">July 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>OCT-measured in-scaffold minimal lumen area</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>OCT-measured minimal scaffold area (MSA)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>OCT-measured mean scaffold expansion</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">9</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Optical coherent tomography</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Optical coherent tomography provides more detailed information about the morphology of scaffolds, microstructures and coronary vasculature based on tissue characteristics as compared to conventional IVUS. In spite of angiographic success in BVS placement, further scaffold optimization was required in over a quarter of cases based on OCT findings due to malapposition or scaffold under expansion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IntraVascular UltraSound</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravascular ultrasound guidance has been associated with improved event-free survival compared with angiographic guidance after DES placement.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Optical coherent tomography</intervention_name>
    <description>comparative method for BVS</description>
    <arm_group_label>Optical coherent tomography</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>IntraVascular UltraSound</intervention_name>
    <description>The method of goldstandard for decision stent choice</description>
    <arm_group_label>IntraVascular UltraSound</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 20 years or older

          -  Patients who have at least one epicardial coronary artery lesion with an evidence of
             inducible ischemia

          -  Willing and able to provide informed written consent

          -  Eligible for PCI

        Exclusion Criteria:

          -  Patients presenting with STEMI within 2 weeks

          -  Bypass graft lesion

          -  Lesion with left main disease

          -  Expected length of scaffold &gt; 40 mm

          -  Bifurcation lesion requiring side branch stenting

          -  Small vessels &lt; 2.75 mm

          -  Stented lesion

          -  Suspected coronary spasm even after sufficient nitrate injected

          -  Cases in which the IVUS or OCT imaging catheter failed to cross the lesion

          -  Poor quality IVUS or OCT images

          -  Contraindication to dual anti-platelet therapy

          -  Chronic total occlusion

          -  Angiographically large-sized vessel (&gt;3.5mm of reference lumen diameter)

          -  Life expectancy shorter than 2 years

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <state>Songpa-Gu</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pusan National University Hospital</name>
      <address>
        <city>Pusan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ulsan University Hospital</name>
      <address>
        <city>Ulsan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>June 16, 2016</study_first_submitted>
  <study_first_submitted_qc>June 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2016</study_first_posted>
  <last_update_submitted>September 5, 2018</last_update_submitted>
  <last_update_submitted_qc>September 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Asan Medical Center</investigator_affiliation>
    <investigator_full_name>Young-Hak Kim, MD, PhD</investigator_full_name>
    <investigator_title>Professor in medicine</investigator_title>
  </responsible_party>
  <keyword>OCT</keyword>
  <keyword>IVUS</keyword>
  <keyword>BVS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>This is not a publicly funded trial.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

